146
Participants
Start Date
February 3, 2021
Primary Completion Date
February 3, 2022
Study Completion Date
July 3, 2022
Intervention/Exposure for the GDM Group (Experimental Arm)
"Gestational Diabetes Diagnosis: The intervention for this group involves the diagnostic procedure of the 100-gram oral glucose tolerance test (OGTT) after an initial glucose challenge test (GCT) with a result equal to or greater than 140 mg/dL. The test assesses fasting plasma glucose and post-glucose consumption plasma glucose levels at 1 hour and 2 hours, which is used to diagnose GDM.~Biomarker Analysis: The albumin to high-sensitivity C-reactive protein (hsCRP) ratio is measured as a biomarker to explore its potential role in GDM diagnosis and related pregnancy outcomes."
Intervention/Exposure for the Control Group
"Glucose Challenge Test (GCT): The control group participants are exposed to the glucose challenge test (GCT), where plasma glucose levels are measured one hour after the consumption of 50 grams of glucose. If their glucose levels are below 140 mg/dL, they are categorized as not having GDM.~Biomarker Analysis: Similar to the GDM group, the albumin to hsCRP ratio is measured for participants in the control group to compare the biomarker levels between those with and without GDM."
Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa
Bursa Yuksek Ihtisas Training and Research Hospital
OTHER_GOV
ALI BAHADIRLI
OTHER